One Sentence Ends Amgen Blockbuster's Reign, Judge Says
A single sentence in a patent settlement prevents Amgen Inc. from halting sales of a generic version of its blockbuster calcium-control drug Sensipar, a Delaware federal judge ruled in an opinion...To view the full article, register now.
Already a subscriber? Click here to view full article